EXO-PAN • RESEARCH USE ONLY

Insulin-Secreting Pancreatic Beta Exosomes

Exosomes from insulin-secreting beta cells, enriched with beta-cell–specific regulatory molecules and insulin-related miRNAs.

ISLET-SPECIFIC CARGO

— Released from insulin-secreting beta cells and enriched for beta-lineage regulatory molecules plus insulin-related miRNAs.

METABOLIC MODULATION

— Discussed for tuning systemic glucose handling while protecting residual islets from inflammatory stressors.

IMMUNE–METABOLIC INTERFACE

— Used to blunt autoimmune targeting of beta cells, support insulin sensitivity, and extend protective signaling to diabetic nephropathy models.

Routes

IVIM

Quantities

110 Billion Exosomes

1ml

Compliance · Exosomes

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More